RBC Bioscience Eulerpool News

RBC Bioscience Stock News

RBC Bioscience is being monitored by journalists and investors worldwide. We gather the latest RBC Bioscience news here.

RBC Bioscience Stock Press Releases

RBC Bioscience regularly publishes news on the company's website that are relevant for investors.

RBC Bioscience News 2026

This page contains all current news, analysis and press releases for RBC Bioscience stock (6848.TWO, ISIN: TW0006848005). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at RBC Bioscience.

RBC Bioscience Stock

RBC Bioscience RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes.